[{"NetIncomeLoss_1_Q3_USD":-84023000.0,"PaidInKindInterest_3_Q3_USD":10440000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-3086000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-14324000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermDebt_3_Q3_USD":132819000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":3966000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":24265000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":75027000.0,"DepreciationAndAmortization_3_Q3_USD":8790000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":33500000.0,"EquitySecuritiesFvNiGainLoss_3_Q3_USD":3800000.0,"UndistributedEarningsLossAvailableToCommonShareholdersDiluted_1_Q3_USD":-1868000.0,"UndistributedEarningsLossAvailableToCommonShareholdersDiluted_3_Q3_USD":-8524000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-3086000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-14324000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"IncreaseDecreaseInReceivables_3_Q3_USD":313000.0,"OperatingLeaseLiability_0_Q3_USD":54923000.0,"EquityMethodInvestments_0_Q3_USD":256420000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":24562000.0,"Liabilities_0_Q3_USD":456801000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":43174000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":444000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":10047000.0,"TreasuryStockValue_0_Q3_USD":49464000.0,"ResearchAndDevelopmentInProcess_1_Q3_USD":34884000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":39765000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1177000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":5074000.0,"TreasuryStockShares_0_Q3_shares":7568182.0,"DerivativeGainLossOnDerivativeNet_1_Q3_USD":-1000000.0,"DerivativeGainLossOnDerivativeNet_3_Q3_USD":5900000.0,"LongTermDebtCurrent_0_Q3_USD":18529000.0,"OperatingLeaseExpense_1_Q3_USD":2580000.0,"OperatingLeaseExpense_3_Q3_USD":7550000.0,"AssetsCurrent_0_Q3_USD":105988000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":10285000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":6339500.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":213009000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":63765000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-28509000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":111676000.0,"InterestPaidNet_3_Q3_USD":3148000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1141208000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":51236000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":75176000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-2050000.0,"AccountsReceivableNetCurrent_0_Q3_USD":14768000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-51939000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":257670000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":223509000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":768000.0,"AdjustmentForAmortization_1_Q3_USD":1034000.0,"AdjustmentForAmortization_3_Q3_USD":3018000.0,"MinorityInterest_0_Q3_USD":-60156000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":4400000.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_1_Q3_shares":6459000.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_3_Q3_shares":6459000.0,"EarningsPerShareBasic_1_Q3_USD":-0.33,"EarningsPerShareBasic_3_Q3_USD":-1.05,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":14329000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":96242000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":4.68,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2576000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-385000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":145000.0,"NumberOfReportableSegments_3_Q3_segment":2.0,"CommonStockValue_0_Q3_USD":28000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q3_USD":6295000.0,"OtherAssetsNoncurrent_0_Q3_USD":2125000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-8556000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-83354000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-226245000.0,"RestrictedCash_0_Q3_USD":45000000.0,"NonoperatingGainsLosses_1_Q3_USD":238000.0,"NonoperatingGainsLosses_3_Q3_USD":179000.0,"CostsAndExpenses_1_Q3_USD":94857000.0,"CostsAndExpenses_3_Q3_USD":202476000.0,"CommonStockSharesIssued_0_Q3_shares":261737622.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":185815000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":77307000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":2016000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.009,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.001,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":30000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":7000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":94296000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":9757000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_3_Q3_USD":13312000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":32003000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-86440000.0,"Assets_0_Q3_USD":602085000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":44833000.0,"InterestExpense_1_Q3_USD":2563000.0,"InterestExpense_3_Q3_USD":17686000.0,"AccountsPayableCurrent_0_Q3_USD":22849000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":38639000.0,"LiabilitiesCurrent_0_Q3_USD":92125000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":9985000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":398000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":251211000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":217050000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-118667000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":714000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":669000.0,"ProceedsFromShortTermDebt_3_Q3_USD":7815000.0,"Goodwill_0_Q3_USD":38298000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":669000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":714000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":3961000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-5821000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-566000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":120176000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":3870000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":13900000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-1989000.0,"NetIncomeLoss_3_Q3_USD":-226959000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":29454000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1524000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q3_USD":25373000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":7055000.0,"OperatingLeasePayments_1_Q3_USD":2531000.0,"OperatingLeasePayments_3_Q3_USD":7354000.0,"NumberOfOperatingSegments_3_Q3_segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":46450000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":1213924.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":145284000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":120176000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-85891000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-235483000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.122,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":79967000.0,"LongTermDebtNoncurrent_0_Q3_USD":149459000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":97810000.0,"RestrictedCashNoncurrent_0_Q3_USD":45000000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.33,"EarningsPerShareDiluted_3_Q3_USD":-1.05,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":5.25,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":4170000.0,"InvestmentIncomeInterest_1_Q3_USD":1000.0,"InvestmentIncomeInterest_3_Q3_USD":22000.0,"InventoryNet_0_Q3_USD":2144000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-86398000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-237512000.0,"OperatingIncomeLoss_1_Q3_USD":-83104000.0,"OperatingIncomeLoss_3_Q3_USD":-173995000.0,"CommonStockSharesAuthorized_0_Q3_shares":750000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-4588000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":2344000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":10418000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":41319000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"StockIssuedDuringPeriodValueAcquisitions_1_Q3_USD":6975000.0,"StockIssuedDuringPeriodValueAcquisitions_3_Q3_USD":9544000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.57,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.21,"LiabilitiesAndStockholdersEquity_0_Q3_USD":602085000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":17930000.0,"CommonStockSharesOutstanding_0_Q3_shares":261737622.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-886776000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":17030169.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":11753000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":28481000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":3845000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3840000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":113477000.0,"StockholdersEquity_0_Q3_USD":205440000.0,"ShareBasedCompensation_3_Q3_USD":13312000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":549000.0,"ProfitLoss_1_Q3_USD":-87109000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q3_USD":1083000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1878000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1544000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":1035000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3687000.0,"DerivativeLiabilitiesNoncurrent_0_Q3_USD":42900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":2682068.0,"PreferredStockSharesAuthorized_0_Q3_shares":100000000.0,"ProfitLoss_3_Q3_USD":-241283000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-240569000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]